Clinical Trials Browser

Phase 2 × Recurrence × 3-Iodobenzylguanidine × Clear all

NCT01413503 2018-09-18

A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors

Phase 2 Completed

50 enrolled 7 charts

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence

NCT00013806 2005-06-24

CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study

Phase 2 Unknown

Neuroblastoma, Recurrence